Early-Transmitted Variants and Their Evolution in a HIV-1 Positive Couple: NGS and Phylogenetic Analyses.
HIV T/F variants
HIV deep phylogenetic NGS analyses
HIV evolution
HIV quasispecies
HIV sexual transmission
human immunodeficiency virus (HIV)
mucosal bottleneck
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
19 03 2021
19 03 2021
Historique:
received:
27
01
2021
revised:
12
03
2021
accepted:
17
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
25
8
2021
Statut:
epublish
Résumé
We had access to both components of a couple who became infected with human immunodeficiency virus (HIV)-1 through sexual behavior during the early initial phase of infection and before initiation of therapy. We analyzed blood samples obtained at the time of diagnosis and after six months of combined antiretroviral therapy. Next-generation sequencing (NGS) and phylogenetic analyses were used to investigate the transmission and evolution of HIV-1 quasispecies. Phylogenetic analyses were conducted using Bayesian inference methods. Both partners were infected with an HIV-1 B subtype. No evidence of viral recombination was observed. The lowest intrapersonal genetic distances were observed at baseline, before initiation of therapy, and in particular in the V1V2 fragment (distances ranging from 0.102 to 0.148). One HIV-1 single variant was concluded to be dominant in all of the HIV-1 regions analyzed, although some minor variants could be observed. The same tree structure was observed both at baseline and after six months of therapy. These are the first extended phylogenetic analyses performed on both members of a therapy-naïve couple within a few weeks of infection, and in which the effect of antiretroviral therapy on viral evolution was analyzed. Understanding which HIV-1 variants are most likely to be transmitted would allow a better understanding of viral evolution, possibly playing a role in vaccine design and prevention strategies.
Identifiants
pubmed: 33808903
pii: v13030513
doi: 10.3390/v13030513
pmc: PMC8003824
pii:
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Lancet HIV. 2019 Sep;6(9):e632-e638
pubmed: 31331822
J Virol. 1999 Jan;73(1):152-60
pubmed: 9847317
Nat Rev Microbiol. 2015 Jul;13(7):414-25
pubmed: 26052661
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
AIDS Res Hum Retroviruses. 2008 Apr;24(4):561-71
pubmed: 18426336
BMJ. 2019 Sep 17;366:l5554
pubmed: 31530547
Top Antivir Med. 2019 Apr;27(1):8-25
pubmed: 31136999
J Clin Invest. 2020 Jul 1;130(7):3543-3559
pubmed: 32191639
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Lancet HIV. 2017 Nov;4(11):e475
pubmed: 29096785
J Virol. 2011 Aug;85(15):7523-34
pubmed: 21593162
J Int AIDS Soc. 2019 Aug;22 Suppl 6:e25357
pubmed: 31468731
Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):E1126-34
pubmed: 25713386
Nat Med. 2015 Oct;21(10):1139-41
pubmed: 26322580
J Infect Dis. 2007 Apr 1;195(7):960-4
pubmed: 17330785
Virus Evol. 2016 Jun 08;2(1):vew012
pubmed: 30186625
PLoS Pathog. 2009 Sep;5(9):e1000590
pubmed: 19779560
AIDS Res Hum Retroviruses. 2012 Aug;28(8):857-65
pubmed: 21936750
PLoS Pathog. 2015 Jan 08;11(1):e1004565
pubmed: 25569444
Semin Cancer Biol. 2014 Jun;26:89-98
pubmed: 24316494
AIDS Care. 2020 Mar;32(3):325-329
pubmed: 31530003
Mol Biol Evol. 2008 Jul;25(7):1253-6
pubmed: 18397919
Viruses. 2011 Jun;3(6):861-85
pubmed: 21994758
Mol Biol Evol. 2006 Feb;23(2):254-67
pubmed: 16221896
J Virol. 2014 Jan;88(1):393-402
pubmed: 24155397
J Infect Dis. 2020 Apr 7;221(9):1407-1415
pubmed: 31135883
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1883-8
pubmed: 26858442
BMC Evol Biol. 2007 Nov 08;7:214
pubmed: 17996036
PLoS Biol. 2015 Sep 16;13(9):e1002251
pubmed: 26375597
Nat Commun. 2019 Jul 19;10(1):3193
pubmed: 31324762
Nat Med. 2003 Jun;9(6):727-8
pubmed: 12754504
J Virol. 2010 Jul;84(14):7396-404
pubmed: 20463080
Bioinformatics. 2012 Jun 15;28(12):1647-9
pubmed: 22543367
Nat Rev Microbiol. 2013 May;11(5):327-36
pubmed: 23524517
JCI Insight. 2020 Feb 27;5(4):
pubmed: 32045386
J Virol. 2015 Aug;89(16):8540-55
pubmed: 26041299
PLoS One. 2009 Sep 22;4(9):e7122
pubmed: 19771165
Proc Natl Acad Sci U S A. 2014 May 13;111(19):6860-1
pubmed: 24799684
Virus Evol. 2019 Jan 30;5(1):vey038
pubmed: 30723550
Science. 2014 Jul 11;345(6193):179-83
pubmed: 24968937
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
J Infect Dis. 2008 Apr 1;197(7):1011-5
pubmed: 18419538
Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):E1156-63
pubmed: 22065783
Sci Rep. 2018 Jan 23;8(1):1404
pubmed: 29362487
Nat Rev Immunol. 2002 Jan;2(1):28-36
pubmed: 11905835
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
pubmed: 18490657
Sex Transm Dis. 2019 Nov;46(11):733-736
pubmed: 31644502
PLoS Pathog. 2010 May 13;6(5):e1000890
pubmed: 20485520
J Virol. 2009 Apr;83(8):3556-67
pubmed: 19193811
PLoS One. 2014 Apr 10;9(4):e93428
pubmed: 24722422
J Infect Dis. 2012 Nov;206(9):1433-42
pubmed: 22997233
Nat Med. 2011 Mar;17(3):366-71
pubmed: 21358627
Science. 2009 Mar 6;323(5919):1304-7
pubmed: 19265012
Retrovirology. 2017 Mar 23;14(1):22
pubmed: 28335782
J Theor Biol. 2009 Nov 21;261(2):341-60
pubmed: 19660475